” DSA is a Finnish health care technology company, whose novel BreathPass™ analyzing device and COVID-19 test revolutionize large-scale community-based COVID-19 screening with a low-cost, non-invasive, and highly accurate COVID test. DSA BreathPass™ COVID-19 test sets a new standard for efficiently screening large groups with industry-leading “real-time” test results. ”
Contacts: Sales Director firstname.lastname@example.org
Visiting address: Deep Sensing Algorithms Ltd Oy,
Hämeenkatu 14 C 25, 33100 Tampere, Finland
” The DSA BreathPassTM is a handheld analyzing device intended for diagnosis of COVID-19 by healthcare professionals and for rapid screenings for large crowds. Inside the device there is an array of nano-sensors to detect molecules of biological origin, known as volatile organic compounds (VOC), as signs of infection stemming from the biomarkers known to be produced by the metabolic processes caused by the SARS-CoV-2 virus. ”
” The DSA BreathPassTM uses a non-invasive method for detection of COVID-19 caused by the SARS-CoV-2 coronavirus. The device measures the exhaled breath for 15 to 30 seconds, characterizes the VOCs within breath samples, produces predictions for different health conditions based on Deep Computing algorithms and generates results in few seconds. The DSA BreathPassTM can be used through the Mobile Application and Web-UI.
The DSA BreathPassTM is a fast, easy and affordable testing method for detecting COVID-19 infection that can be done anywhere with a reliable connection to the internet. ”
” We are constantly looking to improve our team with quality individuals to make the entity stronger. We are also looking for business partners for the fast deployment of the potentially life-saving solutions.
If you interested in distribution and re-sales, we would like to hear from you. And if you think you have an opportunity for a clinical patient testing or algorithm teaching, we would be happy to see how it could be facilitated. ”
Do you want to hear more: https://dsa.fi/contact
Keywords: DSA, Covid19, DSABreathPass, SARSCoV2, virus, analyzer, healthcare